Depósito Digital de Documentos de la UAB Encontrados 30 registros  1 - 10siguientefinal  ir al registro: La búsqueda tardó 0.01 segundos. 
1.
10 p, 4.0 MB Eculizumab discontinuation in atypical haemolytic uraemic syndrome : TMA recurrence risk and renal outcomes / Ariceta Iraola, Gema (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Fakhouri, Fadi (CHU de Nantes) ; Sartz, Lisa (Skåne University Hospital (Suècia)) ; Miller, Benjamin (Alexion Pharmaceutical (Estats Units d'Amèrica)) ; Nikolaou, Vasilis (Parexel International (Regne Unit)) ; Cohen, David (Columbia University Medical Center) ; Siedlecki, Andrew M. (Brigham and Women's Hospital (Boston, Estats Units d'Amèrica)) ; Ardissino, Gianluigi (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico) ; Universitat Autònoma de Barcelona
Eculizumab modifies the course of disease in patients with atypical haemolytic uraemic syndrome (aHUS), but data evaluating whether eculizumab discontinuation is safe are limited. Patients enrolled in the Global aHUS Registry who received ≥1 month of eculizumab before discontinuing, demonstrated haematologic or renal response prior to discontinuation and had ≥6 months of follow-up were analysed. [...]
2021 - 10.1093/ckj/sfab005
Clinical Kidney Journal, Vol. 14 (january 2021) , p. 2075-2084  
2.
3 p, 430.0 KB Low factor H-related 5 levels contribute to infection-triggered haemolytic uraemic syndrome and membranoproliferative glomerulonephritis / Gómez Delgado, Irene (Hospital Universitario La Paz (Madrid)) ; Gutiérrez-Tenorio, Josué (Hospital Universitario 12 de Octubre (Madrid)) ; Fraga Rodríguez, Gloria María (Institut d'Investigació Biomèdica Sant Pau) ; Cavero, Teresa (Hospital Universitario 12 de Octubre (Madrid)) ; Arjona, Emilia (Centro de Investigación Biomédica en Red de Enfermedades Raras) ; Sánchez-Corral, Pilar (Centro de Investigación Biomédica en Red de Enfermedades Raras) ; Universitat Autònoma de Barcelona
Dysregulation of the alternative complement pathway is a major pathogenic mechanism in two rare renal diseases: atypical haemolytic uraemic syndrome (aHUS) and membranoproliferative glomerulonephritis (MPGN). [...]
2020 - 10.1093/ckj/sfaa004
Clinical Kidney Journal, Vol. 14 (march 2020) , p. 707-709  
3.
21 p, 4.9 MB The ERA Registry Annual Report 2019 : summary and age comparisons / Boenink, Rianne (University of Amsterdam, Amsterdam, The Netherlands) ; Astley, Megan E. (University of Amsterdam, Amsterdam, The Netherlands) ; Huijben, Jilske A. (University of Amsterdam, Amsterdam, The Netherlands) ; Stel, Vianda S. (University of Amsterdam, Amsterdam, The Netherlands) ; Kerschbaum, Julia (Medical University Innsbruck, Innsbruck, Austria) ; Ots-Rosenberg, Mai (Tartu University Hospital (Tartu, Estònia)) ; Åsberg, Anders A. (Oslo University Hospital (Oslo, Noruega)) ; Lopot, Frantisek (General University Hospital, Prague-Strahov, Czech Republic) ; Golan, Eliezer (7Israel Renal Registry, Ramat Gan, Israel) ; Castro de la Nuez, Pablo (Sistema de Información de la Coordinación Autonómica de Trasplantes de Andalucía (SICATA)) ; Rodríguez Camblor, Marta (Registro de Enfermos Renales Crónicos de Asturias (RERCA)) ; Trujillo-Alemán, Sara (Servicio Canario de la Salud, Islas Canarias) ; Ruiz San Millan, Juan Carlos (Universidad de Cantabria) ; Ucio Mingo, Pablo (Dirección General de Planificación y Asistencia Sanitaria, Valladolid) ; Díaz Gómez, Juan Manuel (Institut d'Investigació Biomèdica Sant Pau) ; Bouzas-Caamaño, M. Encarnación (Servicio Gallego de Salud) ; Artamendi, Marta (Hospital San Pedro, Logroño, La Rioja) ; Aparicio Madre, Manuel I (Oficina Regional de Coordinación de Trasplantes, Region de Madrid) ; Santiuste de Pablos, Carmen (Consejo de Salud de la Región de Murcia) ; Slon Roblero, María Fernanda (Complejo Hospitalario de Navarra) ; Zurriaga, Oscar (Conselleria de Sanitat Universal i Salut Pública) ; Stendahl, Maria E. (Jonkoping Regional Hospital, Jonkoping, Sweden) ; Bell, Samira (University of Dundee, Dundee, UK) ; Idrizi, Alma (UHC Mother Teresa, Tirana, Albania) ; Ioannou, Kyriakos (Cyprus Renal Registry, Nicosia, Cyprus) ; Debska-Slizien, Alicja (Gdansk Medical University, Gdansk, Poland) ; Galvão, Ana A. (Portuguese Society of Nephrology, Coimbra, Portugal) ; De Meester, Johan (Dutch-speaking Belgian Renal Registry (NBVN), Sint-Niklaas, Belgium) ; Resić, Halima (Society of Nephrology and Dialysis of Bosnia and Herzegovina, Sarajevo, Bosnia and Herzegovina) ; Hommel, Kristine (Holbæk Hospital (Dinamarca)) ; Radunovic, Danilo (Clinical Center of Montenegro, Podgorica, Montenegro) ; Pálsson, Runolfur (Landspitali University Hospital (Reykjavík, Islàndia)) ; Lassalle, Mathilde (Agence de la Biomédecine, Saint-Denis La Plaine, France) ; Finne, Patrik (Helsinki University Hospital (Finlàndia)) ; Garcia Bazaga, María De los Ángeles (Servicio Extremeño de Salud) ; Gjorgjievski, Nikola (University Hospital of Nephrology, Skopje, North Macedonia) ; Seyahi, Nurhan (University-Cerrahpasa, Istanbul, Turkey) ; Bonthuis, Marjolein (University of Amsterdam, Amsterdam, The Netherlands) ; Ortiz, Alberto (Universidad Autónoma de Madrid) ; Jager, Kitty J. (University of Amsterdam, Amsterdam, The Netherlands) ; Kramer, Anneke (University of Amsterdam, Amsterdam, The Netherlands) ; Universitat Autònoma de Barcelona
Data on renal replacement therapy (RRT) for end-stage renal disease were collected by the European Renal Association (ERA) Registry via national and regional renal registries in Europe and countries bordering the Mediterranean Sea. [...]
2021 - 10.1093/ckj/sfab273
Clinical Kidney Journal, Vol. 15 (december 2021) , p. 452-472  
4.
16 p, 4.1 MB Association of renin-angiotensin system blockers with COVID-19 diagnosis and prognosis in patients with hypertension : a population-based study / Soler, María José (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Ribera, Aida (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Marsal, Josep Ramon (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Méndez, Ana Belen (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Andrés Villareal, Mireia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Azancot, María A (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Oristrell, Gerard (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Méndez-Boo, Leonardo (Institut Català de la Salut) ; Cohen, Jordana (University of Pennsylvania) ; Barrabés, José A (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Ferreira-González, Ignacio (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública) ; Universitat Autònoma de Barcelona
The effect of renin-angiotensin system (RAS) blockade either by angiotensin-converting enzyme inhibitors (ACEis) or angiotensin-receptor blockers (ARBs) on coronavirus disease 2019 (COVID-19) susceptibility, mortality and severity is inadequately described. [...]
2021 - 10.1093/ckj/sfab161
Clinical Kidney Journal, Vol. 15 (september 2021) , p. 79-94  
5.
6 p, 440.1 KB SGLT2 inhibitors for non-diabetic kidney disease : drugs to treat CKD that also improve glycaemia / Fernandez-Fernandez, Beatriz (Universidad Autónoma de Madrid) ; Sarafidis, Pantelis (Aristotle University of Thessaloniki) ; Kanbay, Mehmet (Hospital Universitari de Bellvitge) ; Navarro-González, Juan F. (Hospital Universitario Nuestra Señora de Candelaria (Santa Cruz de Tenerife)) ; Soler, María José (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Górriz, Jose Luis (Hospital Clínic Universitari (València)) ; Ortiz, Alberto (Universidad Autónoma de Madrid) ; Universitat Autònoma de Barcelona
Sodium-glucose co-transporter-2 (SGLT2) inhibitors decreased cardiovascular (CV) events and improved renal outcomes in CV safety studies in type 2 diabetes melitus (T2DM) patients at high CV risk. Canagliflozin also improved kidney outcomes in diabetic kidney disease in the Canagliflozin and Renal Events in Diabetes and Nephropathy Clinical Evaluationtrial. [...]
2020 - 10.1093/ckj/sfaa198
Clinical Kidney Journal, Vol. 13 Núm. 5 (october 2020) , p. 728-733  
6.
9 p, 369.1 KB Kidney transplantation and COVID-19 renal and patient prognosis / Toapanta, Néstor (Universitat Autònoma de Barcelona. Departament de Medicina) ; Torres, Irina B. (Universitat Autònoma de Barcelona. Departament de Medicina) ; Sellarés, Joana (Universitat Autònoma de Barcelona. Departament de Medicina) ; Chamoun, Betty (Universitat Autònoma de Barcelona. Departament de Medicina) ; Serón, Daniel (Universitat Autònoma de Barcelona. Departament de Medicina) ; Moreso, Francesc (Universitat Autònoma de Barcelona. Departament de Medicina)
Coronavirus disease 2019 (COVD-19) emerged as a pandemic in December 2019. Infection has spread quickly and renal transplant recipients receiving chronic immunosuppression have been considered a population at high risk of infection, complications and infection-related death. [...]
2021 - 10.1093/ckj/sfab030
Clinical Kidney Journal, Vol. 14 (march 2021) , p. i21-i29  
7.
5 p, 463.7 KB COVID-19 and its impact on the kidney and the nephrology community / Soler, María José (Hospital Universitari Vall d'Hebron) ; Batlle, Daniel (Department of Medicine, Division of Nephrology and Hypertension, Northwestern University Feinberg School of Medicine) ; Universitat Autònoma de Barcelona
2021 - 10.1093/ckj/sfab039
Clinical Kidney Journal, Vol. 14 (march 2021) , p. i1-i5  
8.
7 p, 443.9 KB Acute tubulointerstitial nephritis induced by checkpoint inhibitors versus classical acute tubulointerstitial nephritis : are they the same disease? / Draibe, Juliana B. (Hospital Universitari de Bellvitge) ; García-Carro, Clara (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Martinez-Valenzuela, Laura (Hospital Universitari de Bellvitge) ; Agraz Pamplona, Irene (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Fulladosa, Xavier (Hospital Universitari de Bellvitge) ; Bolufer, Monica (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Tango, Ariel (Hospital Universitari de Bellvitge) ; Torras, Joan (Universitat de Barcelona) ; Soler, María José (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
The incidence of acute tubulointerstitial nephritis (ATIN) related to drugs has dramatically increased over recent years. A new subtype of ATIN, apparently different from classical drug-related ATIN, has emerged that has been related to the administration of immune checkpoint inhibitors (ICIs). [...]
2020 - 10.1093/ckj/sfaa027
Clinical Kidney Journal, Vol. 14 (may 2020) , p. 884-890  
9.
8 p, 584.7 KB Upper limb isometric exercise protocolled programme and arteriovenous fistula maturation process / Tapia González, Irati (Universitat Autònoma de Barcelona. Departament de Medicina) ; Esteve Simó, Vicent (Consorci Sanitari Terrassa) ; Ibañez Pallares, Sara (Consorci Sanitari Terrassa) ; Moreno Guzman, Fátima (Consorci Sanitari Terrassa) ; Fulquet Nicolás, Miquel (Consorci Sanitari Terrassa) ; Duarte Gallego, Verónica (Consorci Sanitari Terrassa) ; Saurina Solé, Anna (Consorci Sanitari Terrassa) ; Pou Potau, Mónica (Consorci Sanitari Terrassa) ; Yeste Campos, Montserrat (Consorci Sanitari Terrassa) ; Ramírez de Arellano Serna, Manel (Consorci Sanitari Terrassa)
Arteriovenous fistula (AVF) is the gold standard for vascular access (VA) for end-stage chronic kidney disease (CKD) patients. Post-operative exercises may help to improve maturation. Nevertheless, scarce scientific evidence has been reported about their utility to date. [...]
2020 - 10.1093/ckj/sfz194
Clinical Kidney Journal, Vol. 14 Núm. 2 (February 2021) , p. 688-695  
10.
10 p, 625.3 KB Challenges in primary focal segmental glomerulosclerosis diagnosis : from the diagnostic algorithm to novel biomarkers / Jacobs-Cachá, Conxita (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Vergara, Ander (Hospital Universitari Vall d'Hebron) ; García-Carro, Clara (Red de Investigación Renal) ; Agraz Pamplona, Irene (Red de Investigación Renal) ; Toapanta-Gaibor, Nestor (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Ariceta Iraola, Gema (Hospital Universitari Vall d'Hebron) ; Moreso, Francesc (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Serón, Daniel (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; López-Hellín, Joan (Hospital Universitari Vall d'Hebron) ; Soler, María José (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
Primary or idiopathic focal segmental glomerulosclerosis (FSGS) is a kidney entity that involves the podocytes, leading to heavy proteinuria and in many cases progresses to end-stage renal disease. Idiopathic FSGS has a bad prognosis, as it involves young individuals who, in a considerably high proportion (∼15%), are resistant to corticosteroids and other immunosuppressive treatments as well. [...]
2020 - 10.1093/ckj/sfaa110
Clinical Kidney Journal, Vol. 14 (august 2020) , p. 482-491  

Depósito Digital de Documentos de la UAB : Encontrados 30 registros   1 - 10siguientefinal  ir al registro:
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.